Merck applied for US emergency use authorization for COVID-19 pill | WNT
The treatment, molnupiravir, cut the rate of hospitalization and death by 50% in a trial of mild-to-moderately ill patients who had at least one risk factor for the disease, according to data released.
WATCH THE FULL EPISODE OF 'WORLD NEWS TONIGHT':
WATCH OTHER FULL EPISODES OF WORLD NEWS TONIGHT:
WATCH WORLD NEWS TONIGHT ON HULU: